Article
Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma.
Frontiers in immunology - 1 Jan 2022
Tang Yuqin, Guo Chengbin, Yang Zhao, Wang Yumei, Zhang Yongqiang, Wang Dong
Abstract excerpt
Hepatocellular carcinoma (HCC) is the predominant subtype of primary liver cancer and represents a highly heterogeneous disease, making it hard to predict the prognosis and therapy efficacy. Here, we established a novel tumor immunological phenotype-related gene index (TIPRGPI) consisting of 11 genes by Univariate Cox regression and the least absolute shrinkage and selection operator (LASSO) algorithm to predict...
Topics
Join the communities discussing this publication.
